Literature DB >> 23676615

Visit-to-visit variability of blood pressure: current knowledge and future research directions.

Paul Muntner1, Emily B Levitan.   

Abstract

Blood pressure (BP) is known to vary over time within individuals. Although variability between office visits has traditionally been regarded as a barrier to the accurate measurement of BP, several recent studies have reported strong associations between visit-to-visit variability (VVV) of BP and increased risk for cardiovascular outcomes. In this article, we review data on VVV of BP and outcomes, determinants of high VVV of BP including demographics, medical history, and antihypertensive medication classes and poor adherence. In addition, we will discuss methodological issues related to interpreting data from studies of VVV of BP and data on BP variability assessed outside of the office setting. In conclusion, we highlight pressing research needs related to VVV of BP including those aimed at determining the mechanism underlying high VVV of BP, assessing interventions that lower VVV of BP and the utility of quantifying VVV of BP using measurements obtained in routine clinical practice.

Mesh:

Substances:

Year:  2013        PMID: 23676615     DOI: 10.1097/MBP.0b013e3283624b24

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  8 in total

1.  Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.

Authors:  Adam de Havenon; Nora F Fino; Brian Johnson; Ka-Ho Wong; Jennifer J Majersik; David Tirschwell; Natalia Rost
Journal:  Stroke       Date:  2019-09-20       Impact factor: 7.914

2.  Blood pressure variability: An emerging target for risk reduction in the setting of hypertensive emergency.

Authors:  Adam de Havenon
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-25       Impact factor: 3.738

3.  Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients.

Authors:  Chenhui Tai; Yuxi Sun; Neng Dai; Dachun Xu; Wei Chen; Jiguang Wang; Athanase Protogerou; Thomas T van Sloten; Jacques Blacher; Michel E Safar; Yi Zhang; Yawei Xu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-03       Impact factor: 3.738

4.  Glomerular filtration function decline, mortality, and cardiovascular events: data from the Strong Heart Study.

Authors:  Astrid M Suchy-Dicey; Ying Zhang; Sterling McPherson; Katherine R Tuttle; Barbara Howard; Jason Umans; Dedra S Buchwald
Journal:  Kidney360       Date:  2021-01-28

5.  Reducing Visit-To-Visit Variability in Systolic Blood Pressure for Improving the Progression of Carotid Atherosclerosis and Endothelial Dysfunction in Patients with Hypertension Management.

Authors:  Hongbin Song; Zhendong Liu; Yingxin Zhao; Lin Ye; Fanghong Lu; Hua Zhang; Yutao Diao; Jianchao Xu
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

6.  Number of blood pressure measurements needed to estimate long-term visit-to-visit systolic blood pressure variability for predicting cardiovascular risk: a 10-year retrospective cohort study in a primary care clinic in Malaysia.

Authors:  Hooi Min Lim; Yook Chin Chia; Siew Mooi Ching; Karuthan Chinna
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

7.  Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up.

Authors:  Adam de Havenon; Alen Delic; Shadi Yaghi; Ka-Ho Wong; Jennifer J Majersik; Eric Stulberg; David Tirschwell; Mohammad Anadani
Journal:  Am J Hypertens       Date:  2021-12-01       Impact factor: 3.080

8.  Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the Systolic Hypertension in Europe trial.

Authors:  Azusa Hara; Lutgarde Thijs; Kei Asayama; Lotte Jacobs; Ji-Guang Wang; Jan A Staessen
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.